Sagopilone (BAY86-5302, ZK 219477)
Sponsors
Bayer
Conditions
Breast Cancer, MetastaticBreast NeoplasmsCarcinoma, Non Small Cell LungCarcinoma, Small CellSmall Cell Lung Carcinoma
Phase 1
Phase 2
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer
CompletedNCT00160069
Start: 2005-08-31End: 2009-04-30Updated: 2014-12-04
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
CompletedNCT00288249
Start: 2005-12-31End: 2009-01-31Updated: 2014-12-02
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer
TerminatedNCT00299390
Start: 2006-04-30End: 2007-04-30Updated: 2015-12-31